This Advisory, based on TIP 49, Incorporating Alcohol Pharmacotherapies Into Medical Practice, focuses on medication and related treatment decisions made after screening and assessment for AUD, and medically supervised withdrawal, if necessary. Alcohol consumption should not stop abruptly in those patients who have consumed alcohol regularly over a prolonged period of time. This Advisory is meant as an overview of AUD medications to facilitate abstinence.
You May Also Be Interested In
TIP 49: Incorporating Alcohol Pharmacotherapies Into Medical Practice
This manual provides clinical practice guidelines for using medications in the medication-assisted treatment of alcohol use disorder. It offers guidance on prescribing acamprosate, disulfiram, oral naltrexone, and extended-release injectable naltrexone. The manual also discusses patient management. Access the literature review.
Treatment Improvement Protocol (TIP) 26: Treating Substance Use Disorder in Older Adults
TIP 42: Substance Use Treatment for Persons With Co-Occurring Disorders
TIP 54: Managing Chronic Pain in Adults With or in Recovery From Substance Use Disorders
This guide equips clinicians with information for treating chronic pain in adults living with a history of substance use. The guide discusses chronic pain management, including treatment with opioids. It also includes information about substance use assessments and referrals. Access the literature review.
Medication for the Treatment of Alcohol Use Disorder: Pocket Guide
This pocket guide is designed as a quick reference for information about medication-assisted treatment for alcohol use disorder. It offers a checklist for prescribing medications to patients and provides a list of approved medications for treatment.